Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Neuromodulation. 2020 Sep 17;24(5):870–878. doi: 10.1111/ner.13256

Table 1.

Demographic and clinical features intent-to-treat samples.

Active TBS (n=25) Sham TBS (n=25) p valuea
Demographic Variables
 Age (years, SD) 48.6 (12.8) 53.2 (11.6) 0.19
 Sex, N (%) female 5 (20) 3 (12) 0.44
 Race, n (%)b 0.35
  Caucasian/White 22 (88) 20 (80)
  African American 0 (0) 2 (8)
  American Indian/Alaskan Native 1 (4) 0 (0)
  Multiracial 2 (8) 1 (4)
 Ethnicity, n (%)b 0.37
  Hispanic origin 0 (0) 2 (8)
  Not of Hispanic origin 23 (92) 23 (92)
 Education, n (%)b 0.15
  Less than high school 1 (4) 1 (4)
  High school or equivalent 2 (8) 5 (20)
  Some college 11 (44) 7 (28)
  Trade or vocational degree 3 (12) 0 (0)
  Bachelor’s degree 2 (8) 8 (32)
  Advanced degree and/or education beyond college 2 (8) 3 (12)
 Employment status, n (%)b 0.80
  Full time 6 (24) 4 (16)
  Part time 1 (4) 2 (8)
  Unemployed 10 (40) 9 (36)
  Retired 6 (24) 9 (36)
 Service connected disability, n (%) approved for mental health 14 (56) 17 (68)
Military History
 Branch, n (%)b 0.61
  Army 8 (32) 8 (32)
  Navy 8 (32) 6 (24)
  Marines 2 (8) 1 (4)
  Air Force 0 (0) 3 (12)
Clinical Variables (mean, SD)
 PTSD CAPS-5 Score 47.4 (10.6) 47.9 (10.0) 0.85
 PTSD PCL-5 Score 49.4 (9.4) 50.0 (11.4) 0.85
 Psychiatric Comorbidity, n (%) 47.4 (10.6) 47.9 (10.0) 0.80
  Major Depressive Disorderc 25 (100) 25 (100) 1.00
  Bipolar II, most recent episode depressed 2 (8) 3 (12) 0.64
  Substance Use Disorder (Mild) 16 (64) 11 (44) 0.16
   Opioid use disorder 6 (24) 5 (20) 0.73
 Prior brain stimulation, n (%)
  Transcranial Magnetic Stimulation 0 (0) 2 (8) 0.15
  Electroconvulsive Therapy 2 (8) 1 (4) 0.55
 Mild traumatic brain injury, n (%) 7 (28) 5 (20) 0.51
 Psychiatric History, n (%)
  Suicide attempt(s) 6 (24) 6 (24) 1.00
  Inpatient hospitalization(s) 13 (52) 15 (64) 0.57
DAR (mean, SD)
 Baseline 11.5 (6.3) 14.1 (5.6) 0.13
 Midpoint double blind 9.1 (6.3) 13.2 (5.5) 0.02
 Endpoint double blind 9.4 (6.6) 12.7 (5.9) 0.07
 Midpoint open label 8.8 (6.8) 11.6 (6.5) 0.14
 Endpoint open label 7.8 (6.8) 9.3 (6.5) 0.41
 Follow-up 8.2 (6.5) 10.9 (6.9) 0.17
PSQI (mean, SD)
 Baseline 14.0 (2.9) 13.8 (4.7) 0.86
 Midpoint double blind 11.7 (4.0) 12.8 (4.3) 0.34
 Endpoint double blind 11.3 (3.9) 12.6 (4.8) 0.31
 Midpoint open label 10.6 (3.7) 12.1 (4.9) 0.26
 Endpoint open label 10.2 (3.6) 11.1 (5.1) 0.54
 Follow-up 9.5 (3.3) 10.2 (4.8) 0.58

Abbreviations: SD, Standard deviation; PTSD, posttraumatic stress disorder; CAPS-5, Clinician Administered PTSD Scale for DSM-5; PCL-5, PTSD Checklist for DSM-5. DAR, Dimensions of Anger Reactions scale; PSQI, Pittsburgh Sleep Quality Index.

a

p values represent between group contrast at baseline

b

Total < 100% due to participant non-response

c

Score of ≥ 14 on the 30-Item Inventory of Depressive Symptomology, Self-Report (IDS-SR)

d

p values represent independent samples t-test between groups.